These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16219656)

  • 41. [Pharmacological hypertension therapy].
    Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
    Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
    Baumgart P
    MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
    [No Abstract]   [Full Text] [Related]  

  • 44. Benefits and risks of combination therapy in hypertension.
    Node K
    Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
    [No Abstract]   [Full Text] [Related]  

  • 45. [Blood pressure control in Europe is worse than in the USA].
    Minutolo R
    G Ital Nefrol; 2007; 24(4):284. PubMed ID: 17659496
    [No Abstract]   [Full Text] [Related]  

  • 46. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antihypertensive drugs in diabetic's hypertension].
    Pugliese F
    G Ital Nefrol; 2006; 23 Suppl 34():S26-31. PubMed ID: 16633991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents.
    Prisant LM
    Am J Med; 2008 Aug; 121(8 Suppl):S8-15. PubMed ID: 18638617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do angiotensin II receptor blockers increase the risk of myocardial infarction?
    Verdecchia P; Angeli F; Gattobigio R; Reboldi GP
    Eur Heart J; 2005 Nov; 26(22):2381-6. PubMed ID: 16081468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin inhibition and malignancies: a question of hydration.
    Thornton SN
    J Hum Hypertens; 2010 Mar; 24(3):226. PubMed ID: 20033073
    [No Abstract]   [Full Text] [Related]  

  • 51. A vaccine for hypertension.
    Ménard J
    J Hypertens; 2007 Jan; 25(1):41-6. PubMed ID: 17143170
    [No Abstract]   [Full Text] [Related]  

  • 52. Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy.
    McInnes GT
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S17-20. PubMed ID: 17199214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Utilizing progress in modern antihypertensive therapy. Treating hypertension effectively from the beginning].
    MMW Fortschr Med; 2005 May; 147(19):48. PubMed ID: 15940938
    [No Abstract]   [Full Text] [Related]  

  • 54. Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: European perspective.
    Verdecchia P; Gentile G; Angeli F; Reboldi G
    Pol Arch Med Wewn; 2008 Sep; 118(9):513-6. PubMed ID: 18846987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: American perspective.
    Pimenta E; Oparil S
    Pol Arch Med Wewn; 2008 Sep; 118(9):508-12. PubMed ID: 18846986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementation of 24-hour blood pressure control.
    Hedner T; Kjeldsen S; Narkiewicz K
    Blood Press Suppl; 2010 Feb; 1():3-4. PubMed ID: 20175713
    [No Abstract]   [Full Text] [Related]  

  • 57. An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    Neal B; MacMahon S
    Clin Exp Hypertens; 1999; 21(5-6):517-29. PubMed ID: 10423078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can large-scale trials or meta-analyses demonstrate blood pressure--independent effect of angiotensin receptor blockers?
    Minami J; Ishimitsu T; Matsuoka H
    Hypertension; 2007 Oct; 50(4):e73; author reply e74. PubMed ID: 17724273
    [No Abstract]   [Full Text] [Related]  

  • 59. [Increasingly more young infarct patients. Therapy of hypertension leaves room for improvement].
    MMW Fortschr Med; 2002 Dec; 144(50):63. PubMed ID: 14610872
    [No Abstract]   [Full Text] [Related]  

  • 60. ARBs and Myocardial Infarction.
    Med Lett Drugs Ther; 2005 May; 47(1208):38-9. PubMed ID: 15880086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.